Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

AGM Update

14 Mar 2017 12:16

RNS Number : 4217Z
W.H. Ireland Group PLC
14 March 2017
 

WH Ireland Group Plc

("WH Ireland" or the "Company")

AGM Update

Further to the announcement of 27 February 2017 in which the Company announced it had dispatched a notice of Annual General Meeting to all shareholders ("AGM Notice"), the Company confirms that it has received notice from a shareholder proposing a minor amendment to Resolution 5 as set out in that AGM Notice.

The proposed amendment would, if passed, reduce the directors authority to allot equity securities pursuant to section 551 of the Companies Act 2006 as proposed in the AGM Notice to the authority to allot equity securities in connection with a pre-emptive rights issue up to an aggregate nominal value of £137,438, which is equal to ten per cent. of the nominal value of the issued ordinary share capital of the Company at 24 February 2017. The full text of resolution 5 as proposed to be amended is set out below:

Text of Resolution 5 (which is an ordinary resolution) as proposed to be amended

"5. That, in substitution for any equivalent existing and unexercised authorities and powers, the directors of the Company be and they are hereby generally and unconditionally authorised for the purpose of section 551 of the Companies Act 2006 (the "Act") to exercise all or any of the powers of the Company to allot shares of the Company or to grant rights to subscribe for, or to convert any security into, shares of the Company (such shares and rights being together referred to as "Relevant Securities") comprising equity securities (as defined in section 560(1) of the Act) up to an aggregate nominal amount of £137,437 in connection with a rights issue in favour of ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings and the directors may make such arrangements or exclusions as they consider necessary or appropriate to deal with fractional entitlements or any legal or practical difficulties under the laws of any territory or the requirements of any recognised regulatory body or stock exchange in any territory provided that this authority shall, unless previously renewed, varied or revoked by the Company in general meeting, expire at the conclusion of the next annual general meeting of the Company or on the date which is 6 months after the next accounting reference date of the Company (if earlier) save that the directors of the Company may, before the expiry of such period, make an offer or agreement which would or might require such securities to be allotted after the expiry of such period and the directors of the Company may allot such securities in pursuance of such offer or agreement as if the authority conferred hereby had not expired."

Following consultation with certain of its major shareholders, the board is pleased to confirm that they support the proposed amendment, which will be put to shareholders at the Company's AGM at 24 Martin Lane, London, EC4R 0DR on 30 March 2017 at 9.30 a.m. and recommends that shareholders vote in favour of the proposed amendment and, if passed, Resolution 5 as amended.

For further information please contact:

 

WH Ireland Group plc www.whirelandplc.com

Richard Killingbeck, Chief Executive Officer +44(0) 20 7220 1666

 

 

SPARK Advisory Partners Limited

Mark Brady/Miriam Greenwood

+44(0) 203 368 3551/3550

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUAGWUPMGPC
Date   Source Headline
15th Aug 20232:59 pmRNSResult of General Meeting and Total Voting Rights
31st Jul 20237:25 amRNSPosting of Circular and Notice of General Meeting
28th Jul 20238:53 amRNSResult of Placing
28th Jul 20237:00 amRNSTrading Update & Proposed Placing
22nd Jun 20239:05 amRNSESOT Purchases
15th Jun 20234:57 pmRNSESOT Purchases
24th Apr 20232:11 pmRNSESOT Purchases
21st Apr 20239:20 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSYear End Trading Update
14th Mar 202311:39 amRNSESOT Purchases
9th Feb 20239:10 amRNSESOT Trading
25th Jan 20238:47 amRNSTotal Voting Rights
17th Jan 20238:44 amRNSESOT Purchases
11th Jan 202310:45 amRNSIssue of Equity - Total Voting Rights
20th Dec 20222:08 pmRNSTR-1: Notification of major holdings
16th Dec 202210:19 amRNSRecent appointments across the Group
16th Dec 20227:00 amRNSInterim Results
7th Dec 20227:00 amRNSESOT Purchases
7th Nov 20225:00 pmRNSESOT Trading
4th Nov 20223:45 pmRNSESOT Trading
4th Oct 20228:18 amRNSESOT Purchases
8th Sep 20224:10 pmRNSResult of AGM
8th Sep 20228:23 amRNSESOT Purchases
5th Aug 20227:00 amRNSESOT Purchases
1st Aug 202210:18 amRNSPDMR Shareholding
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
19th Jul 20227:00 amRNSConfirmation of Chairman Appointment
12th Jul 20227:00 amRNSESOT Purchases
20th Jun 20227:00 amRNSESOT Purchases
10th May 20227:00 amRNSNew Debt Capital Markets Business
6th May 20227:37 amRNSESOT Purchases
27th Apr 20224:05 pmRNSIssue of Options
12th Apr 20228:51 amRNSESOT Purchases
31st Mar 20227:00 amRNSBoard Changes
9th Mar 20227:00 amRNSESOT Purchases
17th Feb 202211:23 amRNSPDMR Shareholdings
15th Feb 20227:00 amRNSDirectorate Update
11th Feb 20224:47 pmRNSTR-1: Notification of Major Holdings
11th Feb 20227:00 amRNSTR-1: Notification of Major Holdings
10th Feb 20229:11 amRNSESOT Purchases
7th Feb 202212:39 pmRNSIssue of Equity - Total Voting Rights
24th Jan 20225:12 pmRNSPDMR Shareholdings
18th Jan 20227:00 amRNSPDMR Shareholding
13th Jan 20227:00 amRNSDirectorate Change
6th Jan 20227:00 amRNSESOT Purchases
20th Dec 20217:00 amRNSAppointment of Head of Private Growth Capital
17th Dec 202111:32 amRNSPrivate Capital Team Update
15th Dec 20217:00 amRNSESOT Purchases
7th Dec 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.